Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.

Abstract

Plasmodium falciparum is the major causative agent of malaria, a disease of worldwide importance. Resistance to current drugs such as chloroquine and mefloquine is spreading at an alarming rate, and our antimalarial armamentarium is almost depleted. The malarial parasite encodes two homologous aspartic proteases, plasmepsins I and II, which are essential components of its hemoglobin-degradation pathway and are novel targets for antimalarial drug development. We have determined the crystal structure of recombinant plasmepsin II complexed with pepstatin A. This represents the first reported crystal structure of a protein from P. falciparum. The crystals contain molecules in two different conformations, revealing a remarkable degree of interdomain flexibility of the enzyme. The structure was used to design a series of selective low molecular weight compounds that inhibit both plasmepsin II and the growth of P. falciparum in culture.

Statistics

0204060'99'01'03'05'07'09'11'13'15'17
Citations per Year

246 Citations

Semantic Scholar estimates that this publication has 246 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Silva1996StructureAI, title={Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.}, author={A M Silva and A Y Lee and S V Gulnik and P Maier and J Collins and T N Bhat and P J Collins and R E Cachau and K E Luker and I Y Gluzman and S E Francis and A Oksman and D E Goldberg and J W Erickson}, journal={Proceedings of the National Academy of Sciences of the United States of America}, year={1996}, volume={93 19}, pages={10034-9} }